Publications by authors named "C M Fontaine"

Breast cancer is the most common malignancy among women worldwide, and advances in early detection and treatment have significantly increased survival rates. However, people living beyond breast cancer often suffer from late sequelae, negatively impacting their quality of life. Prehabilitation, focusing on the period prior to surgery, is a unique opportunity to enhance oncology care by preparing patients for the upcoming oncological treatment and rehabilitation.

View Article and Find Full Text PDF

Introduction: Status epilepticus represents a significant neurological emergency, with high morbidity and mortality rates. In addition to standard care, the identification of adjuvant strategies is essential to improve the outcome.

Areas Covered: The authors conducted a narrative review to provide an update on the value of hypothermia as an antiseizure and neuroprotective treatment in status epilepticus.

View Article and Find Full Text PDF

Background: Pain is reported in 66% of cancer patients with advanced disease. Adequate pain management is a cornerstone of comprehensive supportive cancer care.

Purpose: The purpose of this study was to assess pain management in Oncology Units in Belgium.

View Article and Find Full Text PDF
Article Synopsis
  • - Deslorelin is a GnRH-agonist used off-label to control reproduction in female cats, and a study evaluated its safety and effectiveness with a 9.4 mg implant placed in either interscapular or periumbilical locations.
  • - Over the course of the study, 14 female cats were monitored, showing no significant side effects, with 40% exhibiting signs of estrus post-implantation and an average duration of the implant's effect lasting around 790 days.
  • - The treatment led to weight gain in most cats, and importantly, it was reversible as evidenced by some queens being able to mate and conceive after the treatment period ended.
View Article and Find Full Text PDF

After years of studying cardiovascular diseases (CVD) in men due to their higher incidence compared to women, attention is now being paid to female CVD and their pathophysiology. Even though premenopausal women have a lower incidence of CVD, this disparity progressively diminishes after menopause, highlighting the key role of sex hormones. Many preclinical and fundamental studies have demonstrated protective effects of estrogens on arterial endothelium, suggesting that hormone therapy could improve cardiovascular health in menopausal women.

View Article and Find Full Text PDF